JCC: 与散发性结肠癌相比,IBD相关的结肠癌在DNA甲基化和基因表达谱方面有所不同

2019-08-03 不详 MedSci原创

由于溃疡性结肠炎[UC]相关结直肠癌[CRC]和散发性CRC在临床表现和分子特征上有所不同,本项研究试图评估这两种不同结直肠癌中的DNA甲基化对基因表达影响的差异。

背景和目的
由于溃疡性结肠炎[UC]相关直肠癌[CRC]和散发性CRC在临床表现和分子特征上有所不同,本项研究试图评估这两种不同直肠癌中的DNA甲基化对基因表达影响的差异。

方法
研究人员使用Illumina阵列在11个UC-CRC和邻近组织以及11个散发性CRC和邻近组织中评估DNA甲基化程度。然后对10个UC-CRC和邻近组织以及8个散发性CRC和邻近组织进行RNA测序,评估了DNA甲基化和转录物表达的差异,以及它们在相同组织中的相关性。最后研究人员对三种蛋白质ANPEP,FAM92A1和STK31进行免疫组织化学分析。

结果
本项研究显示33个基因座显示出UC-CRC和邻近组织之间DNA甲基化的差异。相反,散发性结肠癌和邻近组织之间存在4204个差异甲基化位点。886个基因以及10个长的非编码RNA [lncRNA]在UC-CRC和相邻组织之间差异表达。虽然UC和散发性CRC之间没有差异甲基化位点,但UC-CRC和散发性CRC之间有997个基因和38个lncRNA差异表达。在UC中,18个基因表现出DNA甲基化和转录物表达之间的负相关。

结论
本项研究表明机体通过DNA甲基化调节转录物表达导致相关不同结肠癌的发生。炎性肠病和散发性结肠癌之间的表现和结果是存在差异的。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2043023, encodeId=e1f520430230c, content=<a href='/topic/show?id=88535e63128' target=_blank style='color:#2F92EE;'>#散发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57631, encryptionId=88535e63128, topicName=散发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Thu May 28 14:08:00 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933333, encodeId=1aa219333335b, content=<a href='/topic/show?id=01624189383' target=_blank style='color:#2F92EE;'>#基因表达谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41893, encryptionId=01624189383, topicName=基因表达谱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Wed Apr 29 01:08:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263533, encodeId=16961263533b7, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348104, encodeId=d121134810426, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=)]
    2020-05-28 zxxiang
  2. [GetPortalCommentsPageByObjectIdResponse(id=2043023, encodeId=e1f520430230c, content=<a href='/topic/show?id=88535e63128' target=_blank style='color:#2F92EE;'>#散发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57631, encryptionId=88535e63128, topicName=散发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Thu May 28 14:08:00 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933333, encodeId=1aa219333335b, content=<a href='/topic/show?id=01624189383' target=_blank style='color:#2F92EE;'>#基因表达谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41893, encryptionId=01624189383, topicName=基因表达谱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Wed Apr 29 01:08:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263533, encodeId=16961263533b7, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348104, encodeId=d121134810426, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2043023, encodeId=e1f520430230c, content=<a href='/topic/show?id=88535e63128' target=_blank style='color:#2F92EE;'>#散发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57631, encryptionId=88535e63128, topicName=散发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Thu May 28 14:08:00 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933333, encodeId=1aa219333335b, content=<a href='/topic/show?id=01624189383' target=_blank style='color:#2F92EE;'>#基因表达谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41893, encryptionId=01624189383, topicName=基因表达谱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Wed Apr 29 01:08:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263533, encodeId=16961263533b7, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348104, encodeId=d121134810426, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=)]
    2019-08-04 bnurmamat
  4. [GetPortalCommentsPageByObjectIdResponse(id=2043023, encodeId=e1f520430230c, content=<a href='/topic/show?id=88535e63128' target=_blank style='color:#2F92EE;'>#散发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57631, encryptionId=88535e63128, topicName=散发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Thu May 28 14:08:00 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933333, encodeId=1aa219333335b, content=<a href='/topic/show?id=01624189383' target=_blank style='color:#2F92EE;'>#基因表达谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41893, encryptionId=01624189383, topicName=基因表达谱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e5394, createdName=yeaweam, createdTime=Wed Apr 29 01:08:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263533, encodeId=16961263533b7, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348104, encodeId=d121134810426, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Aug 04 15:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=)]

相关资讯

J Gastroenterology: 自然靛蓝治疗溃疡性结肠炎患者的不良事件分析

尽管天然靛蓝(IN)对治疗活动性溃疡性结肠炎(UC)患者有效,但IN与不良事件(AEs)也有很大关系,其中最严重的是出现肺动脉高压(PAH)。奔现研究的目的是评估IN相关AE的发生率,并评估IN对AEs的剂量效应。

JCC:中性粒细胞胞外网状结构维持溃疡性结肠炎的炎症

在溃疡性结肠炎[UC]中,粘膜损伤发生在浸润有中性粒细胞的区域。中性粒细胞的抗微生物功能部分依赖于细胞外网状结构的形成,称为中性粒细胞胞外网[NETs]。异常的NET的形成和/或清除与几种免疫疾病有关。本项研究旨在调查NETs在UC相关炎症中的作用。

J Gastroenterology: 吸烟与溃疡性结肠炎风险之间的剂量-反应关系

吸烟者患溃疡性结肠炎(UC)的风险是明显增高的。然而,根据吸烟量,吸烟行为对UC发生的影响仍然难以捉摸。我们的目的是确定吸烟行为与UC发展风险之间的关系。

JGH:梅奥评分和总胆固醇水平可以作为急性中重度溃疡性结肠炎患者诱导治疗期间粘膜愈合的预测因子

粘膜愈合是溃疡性结肠炎治疗的最终目的,本项研究旨在确定在开始诱导治疗的3个月和12个月时预测溃疡性结肠炎粘膜愈合的标记物。

IBD: 儿童回肠袋肛门吻合术后的短期和长期结果分析

直肠结肠切除术、回肠肛管吻合术(IPAA)已成为溃疡性结肠炎或家族性腺瘤性息肉病恢复肠道连续性的首选方法。本系统评价旨在评估接受IPAA的儿科患者的短期术后和长期功能结果。

DCR:急性重症溃疡性结肠炎拖延结肠切除术预后更差

越来越多的证据支持急性暴发性溃疡性结肠炎应即刻行结肠切除术。本研究的目的是比较溃疡性结肠炎发作患者的早期与延迟急诊结肠切除术的结果。